Australian experience of peptide receptor radionuclide therapy in lung neuroendocrine tumours

Oncotarget
Lisi Elizabeth LimEva Segelov

Abstract

Peptide receptor radionuclide therapy (PRRT) is an approved treatment modality for gastroenteropancreatic neuroendocrine tumours (GEP NETs), Although Phase III randomised clinical trial data is not available for NETs of other site of origin, in practice, PRRT is used more widely in clinical practice, based on its mechanism of targeting the somatostatin receptor. Use of PRRT for lung (bronchial) NET, specifically typical and atypical carcinoid (TC, AC), has been reported only in small retrospective case series. This multicentre study adds to the evidence regarding utility of PRRT for lung NETs. A retrospective chart review of patients with TC and AC who received 177Lu-dotatate PRRT between January 2002 and June 2019 in six hospitals across Australia was undertaken. Data regarding demographics, efficacy and toxicity was evaluated at each site by the treating clinician. Forty-eight patients (32 AC, 15 TC, 1 unclassified) received a median of four 177Lu-dotatate treatments. There was a median of one prior line of systemic treatment (range: 0-3). The response rate to 177Lu-dotatate was 33%, with a median overall survival of 49 months (range of 3-91), at a median follow up of 33 months. This compares favourably with GEP NET. Overall ...Continue Reading

References

Oct 13, 2004·Neuroendocrinology·B G Taal, O Visser
Jan 30, 2007·European Journal of Nuclear Medicine and Molecular Imaging·Martijn van EssenDik J Kwekkeboom
Feb 25, 2010·Annals of Surgical Oncology·Stephen B Edge, Carolyn C Compton
May 11, 2011·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Anna ImhofMartin A Walter
Mar 7, 2012·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Linda VillardMartin A Walter
Feb 8, 2013·European Journal of Nuclear Medicine and Molecular Imaging·L BodeiJohn J Zaknun
Aug 21, 2015·Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer·William D TravisUNKNOWN WHO Panel
Sep 24, 2015·European Journal of Nuclear Medicine and Molecular Imaging·Annapaola MarinielloChiara Maria Grana
Nov 28, 2015·European Journal of Nuclear Medicine and Molecular Imaging·Annarita IannielloGiovanni Paganelli
Dec 26, 2015·Lancet·James C YaoUNKNOWN RAD001 in Advanced Neuroendocrine Tumours, Fourth Trial (RADIANT-4) Study Group
Mar 5, 2016·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Dieter HörschR P Baum
Jan 12, 2017·The New England Journal of Medicine·Jonathan StrosbergUNKNOWN NETTER-1 Trial Investigators
Apr 22, 2017·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Tessa BrabanderDik J Kwekkeboom
Oct 14, 2017·Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine·Thomas A HopeJonathan R Strosberg
Nov 9, 2017·Translational Lung Cancer Research·Giuseppe PelosiMauro Papotti
Jun 5, 2018·Annals of Translational Medicine·Nikolaos TsoukalasGregory Kaltsas
Jun 8, 2018·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Jonathan StrosbergUNKNOWN NETTER-1 Study Group
Jun 13, 2018·Journal of the National Comprehensive Cancer Network : JNCCN·Manisha H ShahGriselda Zuccarino-Catania
Aug 25, 2018·Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc·Guido RindiIan A Cree
Jul 6, 2019·Clinical and Translational Medicine·Mariangela TorniaiRossana Berardi

❮ Previous
Next ❯

Methods Mentioned

BETA
MDS

Clinical Trials Mentioned

NCT03454763
NCT02754297
NCT03629847
NCT03466216

Software Mentioned

LUNA

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.